FDA approves biosimilar to Remicade for arthritis, IBS – UPI.com

April 7, 2016 by  
Filed under Osteo-Arthritis News


UPI.com

FDA approves biosimilar to Remicade for arthritis, IBS
UPI.com
The injectible treatment Inflecta is expected to help many patients with conditions such as IBS and rheumatoid arthritis who could not access or afford the commonly used Remicade after the FDA approved it on April 6, 2016. Photo by Vedmed85/Shutterstock.
FDA Approves Rheumatoid KnockoffWall Street Journal
FDA Approves Rheumatoid Arthritis Biosimilar — UpdateNasdaq
Pfizer Reports Positive Top-Line Results from Phase 3 Trial of Investigational Tofacitinib in Psoriatic ArthritisSonoran Weekly Review
Philadelphia Business Journal –Zacks.com –Tech Times
all 75 news articles »

More Info: Click here

“Finally, you can have the same Revolutionary Yoga Program top athletes use for TOTAL mind-body fitness ... in just 30 minutes a day!”

Speak Your Mind

Tell us what you're thinking...
and oh, if you want a pic to show with your comment, go get a gravatar!

This blog is kept spam free by WP-SpamFree.

Access denied for user ''@'localhost' (using password: NO)